MACROGENICS, INC.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Revenue | $157.7M | $91.9M | $100.9M | $47.8M | $58.0M | $63.8M | $57.2M |
| Cost of Revenue | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — |
| Operating Expenses | |||||||
| Research & Development | $147.2M | $122.1M | $98.3M | $70.2M | $46.6M | $45.4M | $41.1M |
| SG&A Expense | $32.7M | $29.8M | $22.8M | $15.9M | $11.1M | $10.2M | $10.9M |
| Operating Income | $-22.1M | $-60.0M | $-20.2M | $-38.3M | $366.0K | $8.2M | $5.2M |
| Operating Margin | -14.0% | -65.3% | -20.0% | -80.2% | 0.6% | 12.9% | 9.2% |
| Interest Expense | — | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — | — |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | — |
| Net Income | $-19.6M | $-58.5M | $-20.1M | $-38.3M | $-261.0K | $8.4M | $6.7M |
| Net Margin | -12.4% | -63.7% | -20.0% | -80.2% | -0.4% | 13.1% | 11.7% |
| EPS (Basic) | $-0.54 | $-1.69 | $-0.63 | $-1.40 | $-0.01 | $0.00 | $0.00 |
| EPS (Diluted) | $-0.54 | $-1.69 | $-0.63 | $-1.40 | $-0.01 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 36.1M | 34.7M | 31.8M | 27.4M | 27.4M | 26.0M | 24.6M |
| Shares Outstanding (Diluted) | 36.1M | 34.7M | 31.8M | 27.4M | 27.4M | 26.0M | 24.6M |
| Dividends Per Share | — | — | — | — | — | — | — |